SCHEMBL30878254

SCHEMBL30878254

Cc1nc(O)c2cc(S(=O)(=O)C(C)C)ncc2n1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.32
▸ POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30878232 0.84 PIK3CD (0.32) —
SCHEMBL30878231 0.81 EGFR (0.30) —
SCHEMBL30878197 0.78 KIF18A (0.32) —
SCHEMBL31482926 0.73 LOXL2 (0.33) —
SCHEMBL30878193 0.71 PIK3CA (0.37) —
SCHEMBL24800366 0.70 ALDH1A1 (0.35) —
SCHEMBL29863061 0.70 KRAS (0.33) —
SCHEMBL30754558 0.70 TOP1 (0.32) —
SCHEMBL21494875 0.70 KRAS (0.33) —
SCHEMBL27093848 0.70 TOP1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587439-A1 SULFONE-SUBSTITUTED PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF CANCER Bayer Aktiengesellschaft (DE) 2025-07-23 — — EP disclosed
CN-119894893-A Sulfone substituted pyrido [3,4-D ] pyrimidine derivatives for the treatment of cancer 拜耳公司 2025-04-25 — — CN disclosed
WO-2024056782-A1 SULFONE-SUBSTITUTED PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF CANCER BAYER AKTIENGESELLSCHAFT (DE) 2024-03-21 — — WO disclosed
Send feedback